Atlas Trials

OLAParib COmbinations

Clinical trial NCT02576444 · TERMINATED

Trial details

NCT number
NCT02576444
Sponsor
Joseph Paul Eder
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2015-11-01
Primary completion
2019-11-18
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.